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Drimenol, a sesquiterpene alcohol, and its derivatives display diverse bio-activities in nature. How-
ever, a drimenol synthase gene has yet to be identiﬁed. We identiﬁed a new sesquiterpene synthase
cDNA (VoTPS3) in valerian plant (Valeriana ofﬁcinalis). Puriﬁcation and NMR analyses of the VoTPS3-
produced terpene, and characterization of the VoTPS3 enzyme conﬁrmed that VoTPS3 synthesizes
()-drimenol. In feeding assays, possible reaction intermediates, farnesol and drimenyl diphos-
phate, could not be converted to drimenol, suggesting that the intermediate remains tightly bound
to VoTPS3 during catalysis. A mechanistic consideration of ()-drimenol synthesis suggests that
drimenol synthase is likely to use a protonation-initiated cyclization, which is rare for sesquiterpene
synthases. VoTPS3 can be used to produce ()-drimenol, from which useful drimane-type terpenes
can be synthesized.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Terpenoids (or isoprenoids) are one of the major classes of natu-
ral products with 55000 known structures [1]. Terpenoids in ani-
mals serve as primary physiological components of membrane
constituents (e.g., cholesterol) and the electron transport chain
(e.g., ubiquinone), while in plants and microbes, they occur as
diverse secondary metabolites which have beneﬁted human lives
as aromas, ﬂavors, and pharmaceutical substances [2,3]. Terpenoids
of speciﬁc hydrocarbon backbones are synthesized by speciﬁc
terpene synthases (TPSs), which can fold prenyl diphosphate
precursors, such as geranyl (C10), farnesyl (C15), and geranyl geranyl
(C20) diphosphate, with subsequent carbocation formation to
produce a large variety of different terpenoids [4–6]. Hence, at the
entry point of the terpenoid metabolism, the TPS enzyme dictates
terpene skeletal types. In nature, some terpene skeletons (e.g., far-
nesene, caryophyllene, and germacrene) are commonly found in
plants, but others are associated with speciﬁc lineages or species
of plants through evolutionary adaptations (e.g., amorphadienefrom Artemisia annua and (+)-epi-a-bisabolol from Lippia dulcis)
[7,8]. Therefore, it is important to characterize TPSs from diverse
taxa.
Drimane is one of the unique C15 sesquiterpene backbones
(Fig. 1A), of which the biosynthetic gene has not been identiﬁed
[9]. Hundreds of drimane-type sesquiterpenoids have been iso-
lated from plants (primarily Canellaceae and Polygonum families),
liverworts, fungi, and sponges [9–16]. Intriguingly, many of them
show strong biological activities, such as antifungal, plant growth
regulatory and antifeedant effects [9,13,17–19]. Hence, it is appar-
ent that drimane derivatives are widespread in nature and deliver
important eco-physiological roles to the synthesizers. However, it
should be noted that drimane is rarely isolated as a natural product
and that the simplest and closest drimane-type sesquiterpene
found in nature is drimenol (Fig. 1B), which implies that drimenol
or perhaps drimenyl pyrophosphate is the biosynthetic precursor
to the various drimane sesquiterpenoids. A native sesquiterpene
synthase (sesqui-TPS), that can synthesize drimenol from (E,E)-far-
nesyl diphosphate (FPP) in a Mg2+-dependent manner, has been
puriﬁed from the Polygonum hydropiper [20]. This plant produces
a drimane sesquiterpenoid, polygodial (Fig. 1C), which possesses
potent antifeedant activity against insects [9,17,21]. These obser-
vations support that drimenol is the ﬁrst skeletal backbone synthe-
sized from FPP, and that drimenol serves as the central precursor of
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respective gene for drimenol biosynthesis had not been identiﬁed
until now.
2. Materials and methods
2.1. Plasmid construct
Total RNA was isolated from the roots of Valeriana ofﬁcinalis
with 1% of cetyl trimethyl ammonium bromide (0.5 M Tris HCl,
pH. 8.0, 0.25 M ethylene diaminetetraacetic acid (EDTA), 4% NaCl,
0.5% polyvinylpyrrolidone). The cDNA synthesized from total
RNA was used as template for PCR. The PCR products were ampli-
ﬁed with primers (Table S1) and cloned into pESC-Leu2d for yeast
expression, pBluescript II for D307A sub-cloning, and pH9GW or
pDEST17 for Escherichia coli expression.
2.2. Production and puriﬁcation of drimenol in yeast
VoTPS3:pESC-Leu2d or the empty vector was transformed into
the yeast strain, EPY300, and the terpene products from the trans-
genic yeast analyzed, according to published methods [22]. To pur-
ify the VoTPS3-product, the VoTPS3-expressing yeasts were
cultured at 30 C for 6 days in a 1-L cultivation scale. The yeast cul-
ture was extracted with diethyl ether (3  500 mL) and the organic
extracts combined, concentrated and puriﬁed by ﬂash column
chromatography (silica, 45 g; 23 cm height; eluent = 95:5
hexanes:ethyl acetate; 180–250 mL fractions). Drimenol-contain-
ing fractions were pooled, concentrated, and fractionated again
using ﬂash column chromatography (silica, 15 g; 23 cm height;
eluent = dichloromethane; 80180 mL fractions).
2.3. NMR spectroscopy
The puriﬁed product was dried with N2 gas, dissolved in CD3OD
(600 lL) and analyzed by NMR. NMR spectra were recorded on a
Varian Inova 600 MHz or 700 MHz spectrometer equipped with a
13C/1H dual cold probe. d values were referenced to CD3OD
(3.31 ppm) or D2O (4.90 ppm) for 1H-NMR and to CD3OD
(49.0 ppm) for 13C-NMR. Details of 1D and 2D NMR analyses are
given in the Supplementary Materials.
2.4. Overexpression and puriﬁcation of recombinant VoTPS3
An E. coli strain, Rosetta pLysS, harboring VoTPS3-pH9GW or
D307A-pDEST17 was cultured in 500 mL of LB medium at 37 C
for 2 h and induced with 0.1 mM isopropyl b-D-1-thiogalactopyra-
noside at 22 C overnight. The cells were pelleted at 6,000 rpm for
5 min at 4 C and resuspended in lysis buffer (50 mM Na3PO4, pH.Fig. 1. Structures of drimane,7.5, 500 mM NaCl, 20 mM Imidazole). The cells were lysed by son-
ication and then centrifuged at 4000 rpm for 30 min at 4 C. The
soluble fraction was bound with Nickel–Nitrilotriacetic acid resin
(Qiagen, Venlo, Netherlands) for 1 h. Proteins were eluted with
2 mL of elution buffer (50 mM Na3PO4, pH. 7.5, 500 mM NaCl,
50 mM Imidazole), followed by concentration and desalting using
a membrane ﬁlter (Millipore, Massachusetts, USA).
2.5. Enzyme characterization
For the in vitro enzyme assay, 20 lg of puriﬁed enzyme was
mixed with 50 mM Tris (pH 7.5), 10 mM MgCl2 and 100 lM of
(E,E)-FPP (Echelon Biosciences) or 1 mM (E,E)-farnesol (Sigma) or
100 lM of drimenyl diphosphate. The reaction mixture (500 lL)
was overlaid with hexane (500 lL) and incubated at 30 C for 2 h.
The phases were separated and the aqueous layer extracted with
hexane (2  500 lL). The combined hexane extracts were analyzed
by GC–MS. To convert FPP to farnesol or drimenyl diphosphate to
drimenol, the reaction mixture was incubated with 2 units of calf
intestine phosphatase (CIP) (NEB). For the assay using heavy water,
the reaction mixture was incubated with 79% of H2O and 19% of
H218O (Sigma). For kinetic analysis, cold FPP substrates were spiked
with [1-3H]-FPP (Perkin Elmer, 23 Ci mmol1) at 1% of the ﬁnal
concentration. A 100 lL mixture (3.2 lg of enzyme, 25 mM HEPES,
pH. 7.4, 10 mM MgCl2, 0.5–10 lM FPP) was incubated for 5 min at
30 C. The reaction was terminated by adding 4 M NaOH and 1 M
EDTA. The products were mixed with pentane (900 lL) and
400 lL of the upper layer was collected. The pentane extracts were
mixed with 3.5 mL of liquid scintillation cocktail. The radioactivity
of products was monitored by a liquid scintillation counter
(Beckman LS6500). The kinetic parameters were calculated with
the Enzyme Kinetics module in Sigmaplot 12.
2.6. GC–MS analysis
GC–MS analysis was performed with an Agilent 6890N gas
chromatography system, Agilent 5975B mass spectrometer and
DB1-MS column (30 m  250 lm  0.25 lm). 2 lL of sample was
injected at 250 C, and the temperature was increased at a rate of
10 C min1 from 40 C to 250 C. Helium (1 mL min1) was used
as a carrier gas. The National Institute of Standards and Technology
(NIST) Standard Reference Database (version 5) and the Wiley
Registry™ of Mass Spectral Data (version 10) were used to identify
drimenol.
2.7. Quantitative read mapping
Illumina read mapping: for quantitative analysis, CLC Genomics
Workbench software (version 5.5.1) was employed using a singledrimenol, and polygodial.
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insertion cost, 1; deletion cost, 1; length fraction, 0.8; similarity
fraction, 0.98.
3. Results and discussion
3.1. Isolation of new sesqui-TPS from V. ofﬁcinalis
Drimenol was reported in the valerian plant (V. ofﬁcinalis) root
as a minor constituent [23–26], and we searched for the valerian
transcriptome data as a source of drimenol synthase gene isolation.
From the valerian root transcriptome database, generated by 454
sequencing, valerenadiene synthase (VoTPS1) and germacrene
C/D synthase (VoTPS2) were previously identiﬁed and character-
ized [27,28]. To acquire deeper transcript sequencing, Illumina
sequencing was additionally performed, and the resulting reads
were assembled by a Trinity algorithm [29]. The BLAST-searchable
databases of V. ofﬁcinalis 454 and Illumina transcriptomes are
publicly accessible through the PhytoMetaSyn website (www.
phytometasyn.ca) [30,31].
From this transcriptome database, the third full-length sesqui-
TPS cDNA was identiﬁed, and its open reading frame (ORF) was
PCR-ampliﬁed using primers designed at the start and stop codon
of the assembled transcript. The cloned cDNA encodes a polypep-
tide of 556 amino acids with Mw of 64.8 kDa. The newly identiﬁed
sesqui-TPS was named VoTPS3 (GenBank number: JQ437841).
VoTPS3 was quite divergent from other sesqui-TPSs as it displayed
only 41% and 39% sequence identity to VoTPS1 and VoTPS2, respec-
tively, and its closest homolog in the public database showed lim-
ited amino acid identity (49% identity with vetispiradiene synthase
from Solanum tuberosum; GenBank number, BAA82108). To infer
the relative expression level of VoTPS3, 30 million raw Illumina
reads were computationally mapped to VoTPS1/2/3 ORF nucleotide
sequences. In this in silico analysis, VoTPS1 and VoTPS2 showed a
comparable level of expression to each other, but the read count
of VoTPS3 was only 2.4% of VoTPS1 (Table 1). Therefore, VoTPS3
appears to only marginally contribute to the terpene constituents
of the valerian root, in comparison to the VoTPS1 (valerenadiene
synthase) that is responsible for a major sesquiterpenoid, valerenic
acid [27].
3.2. In vivo functional assessment of sesqui-TPS
To assess the catalytic function of VoTPS3, its ORF was expressed
under a galactose-inducible promoter in the EPY300 strain, a yeast
strain engineered to accumulate an elevated level of FPP [32,33].
After galactose-induction, volatile terpenes were sequestered by
dodecane (2 mL) overlaid on the yeast culture (20 mL) during the
3-day cultivation. The dodecane layer was then analyzed by
GC–MS. In the GC–MS proﬁle, a new peak (Fig. 2, peak 2) was iden-
tiﬁed from the yeast expressing VoTPS3, whereas this peak was
absent in the control yeast harboring an empty plasmid. On the
other hand, (E,E)-farnesol (Fig. 2, peak 1) derived from the dephos-
phorylation of FPP was the most abundant compound in the con-
trol yeast, but it was markedly reduced in the yeast expressingTable 1
Quantitative mapping of three valerian sesqui-TPSs.
TPS
name
Reference length (base
pairs)
Unique read
counta
Relative
abundance
VoTPS1 1689 24137 100%
VoTPS2 1692 7674 31.8%
VoTPS3 1671 575 2.4%
a 30362677 reads generated by Illumina sequencings were mapped to the three
reference sequences by the parameters described in the method.VoTPS3. This observation implied that an efﬁcient conversion of
FPP to the new terpene product was occurring in the VoTPS3-
expressing yeast. In the MS spectral database search, the elec-
tron-impact (EI) fragmentation pattern of the new terpene showed
a strong spectral match (98%) to that of drimenol with a parental
m/z of 222. This result indicated that VoTPS3 might catalyze the
synthesis of the sesquiterpene alcohol, drimenol, from FPP.
3.3. Structural elucidation of ()-drimenol
To unambiguously assign the chemical identity of the VoTPS3-
product as drimenol, the cultivation of the yeast expressing VoTPS3
was scaled up to 1-L, and the whole yeast culture was extracted
with diethyl ether (3  500 mL). The diethyl ether fraction was
fractionated using ﬂash column chromatography (see Section 2.2)
to yield 6 mg of the VoTPS3-product with >95% purity. The puriﬁed
terpene was fully characterized by one- and two-dimensional NMR
analyses. 1H-NMR, 13C-NMR, 1H-1H COSY, 1H-13C HSQC, HMBC, and
TOCSY were used to validate the drimenol skeleton. 1D-NOESY
experiments were additionally used to assign the relative stereo-
conﬁguration of the stereo-centers at C5, C9 and C10 (details of
structural determination are given in the Supporting Information).
To determine if the isolated drimenol was the RRR or SSS enantio-
mer, a speciﬁc rotation value was measured, and its [a]D value
compared to a previously reported synthetic SSS standard [34].
Both the isolated drimenol sample and the synthetic literature
compound had comparable negative values (see Supplementary
Materials), which allowed us to assign the absolute conﬁguration
as the SSS enantiomer, ()-drimenol. From these results, we con-
cluded that VoTPS3 encodes the Valeriana ofﬁcinalis ()-drimenol
synthase (VoDMS).
3.4. Characterization of recombinant drimenol synthase
In order to evaluate the kinetic properties of VoDMS, VoDMS
was N-terminally tagged with nine histidines (9His-VoDMS)
and was expressed in E. coli. Approximately, 0.5 mg of the recom-
binant enzyme with 99% purity, as assessed by SDS–PAGE, was
puriﬁed by a Nickel-NTA afﬁnity column (Supplementary
Fig. 1A). Incubation of puriﬁed VoDMS with FPP and the cofactor
Mg2+ resulted in the in vitro synthesis of drimenol (Supplementary
Fig. 1B/C). Furthermore, kinetic properties of VoDMS were
obtained using 3H-labeled FPP. The Km and kcat values of VoDMS
were determined to be 9.6 ± 2.7 lM and 0.025 ± 0.004 s1
(mean ± S.D; n = 3). This result assured that VoDMS encodes a cat-
alytically active sesqui-TPS enzyme.
3.5. Mechanism of drimenol synthesis by VoDMS
Terpene synthases are known to utilize two different mecha-
nisms: (1) Mg2+-dependent ‘‘ionization-initiated’’ reaction (class
I) by cleaving an allylic diphosphate bond or (2) ‘‘protonation-
initiated’’ reaction (class II) by protonating a double-bond at the
terminal isoprene unit (Fig. 3) [35–37]. The ionization-initiated
reaction is mediated by the conserved DDxxD motif, which binds
a divalent metal ion for substrate ionization. On the other hand,
the ‘‘protonation-initiated’’ reaction involves an acidic residue,
often conserved in DxDDmotif, which donates a proton to the dou-
ble-bond at a terminal isoprene unit. Both reactions produce reac-
tive carbocation intermediates which undergo carbocation cascade
reactions to yield various isoprene products. A large majority of
sesqui-TPSs uses the class I ‘‘ionization-initiated’’ mechanism,
whereas the class II ‘‘protonation-initiated’’ reaction is a typical
terpene-forming reaction for triterpene synthases.
As expected, VoTPS sequences align seamlessly with those of
other sesqui-TPSs and possess the conserved DDxxD motif for
Fig. 2. GC–MS analyses of volatiles from VoTPS3-expressing yeast. (A) Gas chromatographic separation of volatile products from empty plasmid and VoTPS3-expressing yeast.
Peaks 1 and 2 are farnesol and VoTPS3-product (drimenol), respectively, and their structures are shown beside the peaks. (B) Mass spectra of VoTPS3-product and its closest
spectral match in the GC–MS library.
Fig. 3. Schematic description of class I and class II reaction mechanisms by terpene synthases.
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the biosynthesis of drimenol using an ‘‘ionization-initiated’’ carbo-
cation formation at C11. However, a simple mechanism for drime-
nol formation by this typical ionization (class I) mechanism is not
readily apparent. Rather, the drimenol formation from FPP can be
postulated without difﬁculty by employing the class II reaction
by protonating at C3 (Fig. 4A). In this mechanism, the reaction pro-
ceeds with a protonation at C3, followed by two sequential double-
bond rearrangements and a deprotonation. Then the cleavage of
diphosphate by DDxxD and Mg2+ could generate a primary carbo-cation which can be quenched by a water molecule. In this model,
both class I and II mechanisms contribute to the formation of
drimenol.
We recognized, however, the occurrence of an unstable primary
carbocation in this mechanism and hence reasoned that drimenol
could be synthesized by an enzymatic hydrolysis of the diphos-
phate. To probe the biosynthetic nature of the alcohol moiety at
C11, VoDMS enzyme was incubated with H218O. If C11 is ionized
by the DDxxD motif and Mg2+, 18O will be incorporated into
drimenol. On the other hand, if a hydrolysis of diphosphate is
Fig. 5. Mass spectra of the drimenol synthesized by VoDMS in the presence of H218O.
Mass spectrum of drimenol synthesized from VoDMS assay with 100% H2O (A) and
with 81% H2O and 19% H218O (B). The m/z value of 222 is measured for drimenol
parental ions with 16O.
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incorporated into the drimenol. With H218O as 19% of total H2O in
the enzyme assay, comparable amount (20.3%) of drimenol paren-
tal ions with two mass increase (m/z = 224) was detected by
GC–MS analysis (Fig. 5). This result proved that the oxygen atom
from water is incorporated into drimenol, supporting the class I
ionization reaction by VoDMS. The proposed homoallylic cation
could be stabilized by its resonance structure, cyclopropylcarbinyl
and cyclobutyl cation (Fig. 4A). In this proposed catalysis, drimenyl
diphosphate is a key intermediate, and thus VoDMS could utilize
drimenol diphosphate as a substrate. To test this possibility, drim-
enyl diphosphate was synthesized from the puriﬁed drimenol and
incubated with VoDMS, but no evidence of drimenol formation
from drimenyl diphosphate was obtained (Supplementary Fig. 3).
From this result, we can deduce two possible explanations: (1)
drimenyl diphosphate is not an intermediate in VoDMS reaction
or (2) drimenyl diphosphate remains tightly bound to the active
site of VoDMS during catalysis. Even though the drimenyl diphos-
phate is an intermediate in VoDMS reaction, it is apparent that
VoDMS does not have a separate active site for the intermediate
(i.e., drimenyl diphosphate) as shown in the bifunctional abietadi-
ene synthase that encodes two distinct active sites in a single poly-
peptide [38].
A triterpene synthase-class enzyme, squalene-hopene cyclase,
has been shown to catalyze an enzymatic conversion of (E,E)-farne-
sol to drimenol by its promiscuous protonation activity on the C3
of farnesol [35,39,40]. Based on this observation, we investigated
if farnesol could be an intermediate of the VoDMS reaction as
shown in Fig. 4B. In this model, ionization occurs at C11, and the
C11 carbocation is immediately quenched by a water molecule,
yielding a farnesol intermediate. Farnesol can undergo C3 proton-
ation, double-bond rearrangements, and deprotonation to produce
drimenol. To test this possible mechanism, we incubated VoDMS
with up to 10 mM of the farnesol substrate. However, no evidence
of drimenol formation was obtained from this assay (Supplemen-
tary Fig. 4), suggesting that farnesol is not likely to be an interme-Fig. 4. A proposed biosynthetic mechanism of drimenol catalyzed by drimenol syntha
followed by double-bond rearrangement and a quench by H2O. (B) Ionization at C11 occu
is further cyclized to drimenol by a protonation at C3. FPP can be converted to farneso
hydroxyl group of serine residue in phosphatase.diate in the VoDMS reaction. Despite this result, we cannot exclude
the possibility that the enzyme initially binds only FPP, which may
induce a conformational change so that exogenous farnesol cannot
access the active site despite the possible transient existence of
that species during the reaction.se. See Fig. 1 for carbon numbers. (A) Protonation at C3 of drimenol occurs ﬁrst,
rs ﬁrst, followed by a quench by a H2O and farnesol intermediate formation. Farnesol
l by a phosphatase enzyme reaction, in which phosphorus in FPP is attacked by a
4602 M. Kwon et al. / FEBS Letters 588 (2014) 4597–4603It is unprecedented that a sesqui-TPS possesses both class I and
class II reactivity in a single polypeptide. We attempted to decou-
ple the class I (ionization) and class II (protonation) reaction by
mutating the DDxxD motif in VoDMS. The ﬁrst Asp residue of the
DDxxD motif, known to ionize the substrate in concert with
Mg2+, was mutated to Ala to generate an ADxxD motif (D307A).
This mutant enzyme, possessing the weakened metal-binding
motif, was incubated with FPP, and the product was dephosphoryl-
ated by phosphatase and analyzed by GC–MS. From this experi-
ment, we aimed to examine the possibility that the substrate FPP
binds, although weakly, to the active site, but is not ionized due
to the D307A point-mutation in the conserved DDxxD motif. While
FPP is being bound to the mutant enzyme, C3-protonation could
still occur to produce drimane-diphosphate, which can be con-
verted to drimenol by phosphatase treatment. However, in assays
using the mutant VoDMS, drimenol was not detected by GC–MS
analysis (Supplementary Fig. 5).
Taken together, a speciﬁc reaction mechanism could not be
inferred either by feeding farnesol or drimenyl diphosphate to
the enzyme or by using the weakened metal-biding motif (ADxxD;
D307A). However, these results need to be cautiously interpreted.
During the reaction, the reaction intermediates (farnesol or drime-
nyl diphosphate) could be deeply buried in the substrate-binding
site of VoDMS by the conformational change of the enzyme, and
hence exogenous intermediates may not be accessible to the active
site. Also, FPP may not be able to bind strongly to the active site of
the mutant VoDMS (D309A). Therefore, the lack of evidence for
C3-protonation from these experiments cannot exclude the class
II reaction in VoDMS. We predict that an unrevealed acidic residue
in VoDMS may play a critical role in protonation.
4. Conclusion
In summary, a new sesqui-TPS, identiﬁed from the valerian root
transcriptomic analysis, was comprehensively characterized and
demonstrated to encode a ()-drimenol synthase (VoDMS). Drim-
enol can serve as a useful synthon for the semi-synthetic prepara-
tions of various bioactive drimane-type sesquiterpenes. Hence, the
VoDMS can be used to biologically synthesize drimenol, as shown
in our yeast system. VoDMS appears to utilize both class I (ioniza-
tion) and class II (protonation) mechanisms in a single active site
that are unprecedented among the known sesqui-TPSs.
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